Latest AI and machine learning research in other cancers for healthcare professionals.
Ovarian cancer is associated with high rates of patient mortality and morbidity. Laparoscopic assessment of tumor localization can be used for treatment planning in newly diagnosed high-grade serous ovarian carcinoma (HGSOC). While spread to multiple intra-abdominal areas is correlated with worse outcomes, whether other morphological tumor differences are also associated with patient outcomes is u...
PURPOSE: Anti-PD-1 antibodies are widely used for cancer treatment, including in advanced renal cell carcinoma (RCC). However, the therapeutic response varies among patients. This study aimed to predict tumor response to nivolumab anti-PD-1 antibody treatment for advanced RCC by integrating genetic and clinical data using machine learning (ML).
BACKGROUND: Oral Immunotherapy (OIT) has exhibited great potential in the treatment of food allergy. However, there is no global consensus on best pra...
Digital pathology (DP) has significantly transformed breast pathology at Mount Sinai Hospital by enhancing diagnostic accuracy, collaboration, and edu...
BACKGROUND: The last decade has witnessed a surge in artificial intelligence (AI). With bone metastases becoming more prevalent, there is an increasin...
The principal aim of the present study was to develop and validate a nomogram predicting overall survival (OS) in patients with α-fetoprotein (AFP)-ne...
Artificial intelligence (AI) has revolutionized various biomedical fields, particularly immunology, by enhancing vaccine development, immunotherapies,...
Breast cancer is the most prevalent cancer and the second cause of cancer related death among women in the United States. Accurate and early detection...
Glioma, a malignant intracranial tumor with high invasiveness and heterogeneity, significantly impacts patient survival. This study integrates multi-o...
PURPOSE: Despite the development of diverse treatment options, there has been an increase in mortality rates for laryngeal squamous cell carcinoma (LS...
The classification and diagnosis of pancreatic tumors present significant challenges due to their inherent complexity and variability. Traditional met...
BACKGROUND: Autoantibodies represent promising diagnostic blood-based biomarkers that may be generated prior to the first clinically detectable signs ...
Drug resistance is one of the main reasons for cancer treatment failure, leading to a rapid recurrence/disease progression of the cancer. Recently, ar...
BACKGROUND: Palliative care is a key component of integrated care to improve care quality and reduce hospitalization costs for patients with chronic o...
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common primary liver cancer worldwide, and early pathological diagnosis is crucial for formulat...
Papillary thyroid carcinoma (PTC) is a common endocrine malignancy with a generally favorable prognosis, but lymph node metastasis (LNM) complicates t...
Lung cancer remains the leading cause of cancer-related deaths globally, often detected in advanced stages with poor prognosis. While surgical resecti...
The presence of axillary lymph node metastasis (ALNM) in breast cancer patients is an important factor in deciding whether to have axillary surgery or...
BACKGROUND: Invasive micropapillary carcinoma (IMPC) is a rare subtype of breast cancer characterized by a high risk of lymph node metastasis (LNM). T...
Background This investigation delves into the potential application of data-driven survival modeling approaches for prognostic assessments of breast c...